文献速递临床试验与 GCP

急性冠脉综合征中血管内超声指导与造影指导经皮冠状动脉介入治疗(IVUS-ACS):两阶段、多中心、随机试验

Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial.
PubMed 文献 · Lancet · 2024-04-08

该两阶段多中心随机试验在中国、意大利、巴基斯坦和英国的58个中心纳入3505例急性冠脉综合征患者,随机分入血管内超声指导或造影指导经皮冠状动脉介入治疗。1年靶血管失败率血管内超声组4.0% vs 造影组7.3%(HR 0.55,95%CI 0.41-0.74;p=0.0001),全因死亡和支架血栓无显著差异。

要点

  • 急性冠脉综合征患者1年靶血管失败率血管内超声组4.0% vs 造影组7.3%(HR 0.55,95%CI 0.41-0.74;p=0.0001)。
  • 靶血管心肌梗死或靶血管血运重建的降低驱动了主要终点获益。
  • 两组全因死亡、支架血栓及安全终点无显著差异。

核心结论

  • 在急性冠脉综合征患者中,血管内超声指导植入当代药物洗脱支架相比单纯造影指导,降低了1年心脏死亡、靶血管心肌梗死或临床驱动血运重建复合结局的发生率。

研究设计与样本

  • 两阶段、多中心、随机试验,纳入中国、意大利、巴基斯坦和英国58个中心年龄18岁及以上急性冠脉综合征患者。
  • 2019年8月20日至2022年10月27日随机分配3505例患者至血管内超声指导经皮冠状动脉介入治疗(n=1753)或造影指导经皮冠状动脉介入治疗(n=1752)。
  • 患者、随访医护人员和评估者设盲,导管室工作人员未设盲;主要终点为随机化后1年靶血管失败(心脏死亡、靶血管心肌梗死或临床驱动靶血管血运重建的复合终点)。
  • 试验注册号ClinicalTrials.gov NCT03971500,已完成。

主要发现

  • 3504例(>99.9%)患者完成1年随访。
  • 主要终点在血管内超声组70例和造影组128例发生(Kaplan-Meier率4.0% vs 7.3%;风险比0.55[95%CI 0.41-0.74];p=0.0001),由靶血管心肌梗死或靶血管血运重建的降低驱动。
  • 两组全因死亡或支架血栓无显著差异,安全终点也相似。

关键数值与推荐

  • 主要终点1年靶血管失败率:血管内超声组4.0% vs 造影组7.3%(HR 0.55,95%CI 0.41-0.74;p=0.0001)。

临床怎么用

  • 作者结论认为,在急性冠脉综合征患者中,血管内超声指导植入当代药物洗脱支架相比单纯造影指导可降低1年复合终点发生率。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intravascular ultrasound-guided percutaneous coronary intervention has been shown to result in superior clinical outcomes compared with angiography-guided percutaneous coronary intervention. However, insufficient data are available concerning the advantages of intravascular ultrasound guidance for patients with an acute coronary syndrome. This trial aimed to investigate whether the use of intravascular ultrasound guidance, as compared with angiography guidance, improves the outcomes of percutaneous coronary intervention with contemporary drug-eluting stents in patients presenting with an acute coronary syndrome. METHODS: In this two-stage, multicentre, randomised trial, patients aged 18 years or older and presenting with an acute coronary syndrome at 58 centres in China, Italy, Pakistan, and the UK were randomly assigned to intravascular ultrasound-guided percutaneous coronary intervention or angiography-guided percutaneous coronary intervention. Patients, follow-up health-care providers, and assessors were masked to random assignment; however, staff in the catheterisation laboratory were not. The primary endpoint was target vessel failure, a composite of cardiac death, target vessel myocardial infarction, or clinically driven target vessel revascularisation at 1 year after randomisation. This trial is registered at ClinicalTrials.gov, NCT03971500, and is completed. FINDINGS: Between Aug 20, 2019 and Oct 27, 2022, 3505 patients with an acute coronary syndrome were randomly assigned to intravascular ultrasound-guided percutaneous coronary intervention (n=1753) or angiography-guided percutaneous coronary intervention (n=1752). 1-year follow-up was completed in 3504 (>99·9%) patients. The primary endpoint occurred in 70 patients in the intravascular ultrasound group and 128 patients in the angiography group (Kaplan-Meier rate 4·0% vs 7·3%; hazard ratio 0·55 [95% CI 0·41-0·74]; p=0·0001), driven by reductions in target vessel myocardial infarction or target vessel revascularisation. There were no significant differences in all-cause death or stent thrombosis between groups. Safety endpoints were also similar in the two groups. INTERPRETATION: In patients with an acute coronary syndrome, intravascular ultrasound-guided implantation of contemporary drug-eluting stents resulted in a lower 1-year rate of the composite outcome of cardiac death, target vessel myocardial infarction, or clinically driven revascularisation compared with angiography guidance alone. FUNDING: The Chinese Society of Cardiology, the National Natural Scientific Foundation of China, and Jiangsu Provincial & Nanjing Municipal Clinical Trial Project. TRANSLATION: For the Mandarin translation of the abstract see Supplementary Materials section.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. Li X, Ge Z, Kan J, et al. Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial. Lancet. 2024. PMID: 38604212. doi:10.1016/S0140-6736(24)00282-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。